TotalMarketCap

Aspire-Lakewood

ASBPNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$11.389 M

$8.12 -2.75%

Close of 2 Oct 2026

Revenue

$6.20K

#3629 by revenue

Earnings

-$24.5M

Loss-making

Shares outstanding

1,402,557

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Other share classes

Aspire-Lakewood lists more than one class of stock. Company figures above cover all classes combined.

ASBPW

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 500 →
  1. #419Phio PharmaceuticalsPHIO$11.6M
  2. #420Kiora PharmaceuticalsKPRX$11.4M
  3. #421Aspire-LakewoodASBP$11.4M
  4. #422CalciMedicaCALC$11.3M
  5. #423GT BiopharmaGTBP$11.2M

What if Aspire-Lakewood were worth as much as…

Open the what-if tool →

Gold $28.8T

$20,541,735

Per share 2,529,770× higher

Bitcoin $1.70T

$1,212,372

Per share 149,307× higher

Nvidia $5.56T

$3,966,845

Per share 488,528× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for Aspire-Lakewood are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 3 Oct 2026. Read the methodology.